REQUEST A DEMO
Total
USD $0.00
Search more companies

Abc Pharma SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Abc Pharma SIA Profile Updated: July 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Abc Pharma SIA is based in Latvia. The head office is in Riga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on November 14, 2013. It currently has a total number of 15 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 0.71% in 2025. During that time, Abc Pharma SIA’s total assets decreased by 4.09%. Abc Pharma SIA’s net profit margin decreased by 2.51% in 2025.

Headquarters
Kruzes iela 38
Riga; Riga; Postal Code: 1002

Contact Details: Purchase the Abc Pharma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Abc Pharma SIA report to view the information.
Registered Capital:
Purchase the Abc Pharma SIA report to view the information.
Financial Auditors:
Purchase the Abc Pharma SIA report to view the information.
Incorporation Date:
November 14, 2013
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Abc Pharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
0.71%
Total Operating Revenue
0.58%
Operating Profit
-15.01%
Net Profit/Loss for the Period
-18.83%
Total Assets
-4.09%
Total Equity
-7.95%
Operating Profit Margin
-2.36%
Net Profit Margin
-2.51%
Return on Equity (ROE)
-6.91%
Quick Ratio
-0.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?